Concepts (139)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Methylation | 7 | 2025 | 1093 | 2.090 |
Why?
|
| Genomic Imprinting | 4 | 2021 | 127 | 1.690 |
Why?
|
| Oocytes | 4 | 2025 | 283 | 1.220 |
Why?
|
| Transcriptome | 2 | 2025 | 1141 | 1.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2026 | 635 | 0.950 |
Why?
|
| Hydatidiform Mole | 3 | 2025 | 19 | 0.930 |
Why?
|
| Zygote | 1 | 2025 | 29 | 0.910 |
Why?
|
| Loss of Function Mutation | 1 | 2025 | 163 | 0.810 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2023 | 22 | 0.800 |
Why?
|
| Epigenesis, Genetic | 5 | 2025 | 771 | 0.770 |
Why?
|
| Histone Demethylases | 1 | 2023 | 43 | 0.760 |
Why?
|
| Germ Cells | 1 | 2021 | 203 | 0.640 |
Why?
|
| Genes, Wilms Tumor | 1 | 2019 | 5 | 0.610 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2016 | 34 | 0.590 |
Why?
|
| Spermatozoa | 2 | 2018 | 257 | 0.560 |
Why?
|
| Wilms Tumor | 1 | 2019 | 120 | 0.540 |
Why?
|
| Proteins | 4 | 2025 | 1014 | 0.480 |
Why?
|
| Repressor Proteins | 3 | 2016 | 781 | 0.440 |
Why?
|
| Kidney Neoplasms | 1 | 2019 | 454 | 0.440 |
Why?
|
| RNA, Long Noncoding | 1 | 2017 | 232 | 0.420 |
Why?
|
| Infertility, Male | 1 | 2017 | 297 | 0.410 |
Why?
|
| Embryonic Development | 2 | 2026 | 224 | 0.410 |
Why?
|
| Mutation | 4 | 2021 | 6197 | 0.400 |
Why?
|
| Abortion, Habitual | 2 | 2025 | 17 | 0.360 |
Why?
|
| Pre-Eclampsia | 2 | 2012 | 223 | 0.350 |
Why?
|
| Consanguinity | 2 | 2019 | 119 | 0.350 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2026 | 1005 | 0.300 |
Why?
|
| Pregnancy | 9 | 2026 | 7588 | 0.270 |
Why?
|
| Homozygote | 3 | 2025 | 548 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 3428 | 0.240 |
Why?
|
| Mice, Knockout | 3 | 2026 | 3864 | 0.230 |
Why?
|
| Embryonic Stem Cells | 2 | 2023 | 160 | 0.210 |
Why?
|
| HLA-G Antigens | 1 | 2023 | 13 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2023 | 38 | 0.200 |
Why?
|
| Activins | 1 | 2023 | 73 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2023 | 51 | 0.200 |
Why?
|
| Female | 13 | 2026 | 71375 | 0.200 |
Why?
|
| Maternal Inheritance | 1 | 2023 | 13 | 0.200 |
Why?
|
| Trophoblasts | 1 | 2023 | 117 | 0.190 |
Why?
|
| Congenital Abnormalities | 1 | 2026 | 323 | 0.180 |
Why?
|
| Methylation | 3 | 2018 | 199 | 0.180 |
Why?
|
| Placenta | 3 | 2026 | 526 | 0.170 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2019 | 72 | 0.170 |
Why?
|
| RNA-Binding Proteins | 1 | 2025 | 551 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 464 | 0.160 |
Why?
|
| Infertility, Female | 2 | 2019 | 153 | 0.160 |
Why?
|
| Methylmalonyl-CoA Mutase | 1 | 2020 | 4 | 0.160 |
Why?
|
| Sperm Motility | 2 | 2019 | 113 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2019 | 359 | 0.160 |
Why?
|
| Iran | 3 | 2020 | 98 | 0.160 |
Why?
|
| Preimplantation Diagnosis | 1 | 2020 | 27 | 0.150 |
Why?
|
| Blastocyst | 1 | 2019 | 78 | 0.150 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 1226 | 0.150 |
Why?
|
| Humans | 16 | 2026 | 132031 | 0.150 |
Why?
|
| Asthenozoospermia | 1 | 2019 | 6 | 0.150 |
Why?
|
| Hypercalciuria | 1 | 2019 | 9 | 0.150 |
Why?
|
| Adenylyl Cyclases | 1 | 2019 | 63 | 0.150 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2019 | 2871 | 0.150 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2019 | 12 | 0.150 |
Why?
|
| Animals | 6 | 2026 | 34258 | 0.150 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2019 | 74 | 0.150 |
Why?
|
| Kidney Calculi | 1 | 2019 | 48 | 0.150 |
Why?
|
| Ovulation Induction | 1 | 2019 | 41 | 0.140 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2020 | 113 | 0.140 |
Why?
|
| Uterine Neoplasms | 1 | 2019 | 107 | 0.140 |
Why?
|
| Lysine | 2 | 2016 | 165 | 0.140 |
Why?
|
| Semen Analysis | 1 | 2018 | 37 | 0.140 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2018 | 65 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 1850 | 0.140 |
Why?
|
| Mice | 5 | 2026 | 18392 | 0.140 |
Why?
|
| Oxytocin | 1 | 2018 | 71 | 0.140 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2018 | 45 | 0.140 |
Why?
|
| Cell Differentiation | 2 | 2023 | 1950 | 0.140 |
Why?
|
| Aspirin | 1 | 2019 | 217 | 0.130 |
Why?
|
| Epigenomics | 1 | 2018 | 182 | 0.130 |
Why?
|
| Spermatogenesis | 1 | 2017 | 171 | 0.120 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Nucleotide Motifs | 1 | 2015 | 50 | 0.120 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 233 | 0.110 |
Why?
|
| Histones | 2 | 2016 | 543 | 0.110 |
Why?
|
| Protein Binding | 2 | 2015 | 1673 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2018 | 1105 | 0.100 |
Why?
|
| Recurrence | 1 | 2018 | 1484 | 0.100 |
Why?
|
| Alleles | 2 | 2015 | 1708 | 0.100 |
Why?
|
| Adult | 7 | 2025 | 31744 | 0.100 |
Why?
|
| Phenotype | 2 | 2020 | 4540 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2012 | 145 | 0.090 |
Why?
|
| Base Sequence | 1 | 2015 | 2783 | 0.090 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2019 | 2020 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 181 | 0.080 |
Why?
|
| Cell Line | 1 | 2015 | 2590 | 0.080 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 2364 | 0.080 |
Why?
|
| Male | 5 | 2025 | 65420 | 0.080 |
Why?
|
| DNA | 1 | 2013 | 1440 | 0.070 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1407 | 0.060 |
Why?
|
| Signal Transduction | 1 | 2019 | 4696 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2012 | 3457 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4731 | 0.060 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 894 | 0.060 |
Why?
|
| DNA-Binding Proteins | 1 | 2013 | 1965 | 0.050 |
Why?
|
| Transcription Factors | 1 | 2013 | 2444 | 0.050 |
Why?
|
| Acyl Coenzyme A | 1 | 2020 | 23 | 0.040 |
Why?
|
| Cyclic CMP | 1 | 2019 | 1 | 0.040 |
Why?
|
| Oocyte Retrieval | 1 | 2019 | 5 | 0.040 |
Why?
|
| Karyotyping | 1 | 2019 | 313 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 204 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2018 | 203 | 0.030 |
Why?
|
| Fertilization in Vitro | 1 | 2019 | 160 | 0.030 |
Why?
|
| DNA Mutational Analysis | 1 | 2019 | 804 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 366 | 0.030 |
Why?
|
| Risk Factors | 1 | 2010 | 11019 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1718 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2020 | 937 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2019 | 1637 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 341 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 934 | 0.030 |
Why?
|
| Calcium | 1 | 2019 | 1039 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2019 | 1746 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8613 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 1148 | 0.020 |
Why?
|
| Insulin | 1 | 2018 | 1152 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2018 | 683 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2016 | 752 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2019 | 13024 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1279 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2013 | 622 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2018 | 1697 | 0.020 |
Why?
|
| Young Adult | 2 | 2019 | 10127 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2012 | 318 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2012 | 751 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2013 | 489 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2018 | 3850 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 2422 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 705 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3534 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2013 | 2946 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 2655 | 0.020 |
Why?
|
| Infant | 1 | 2020 | 13343 | 0.010 |
Why?
|
| Child | 1 | 2020 | 26358 | 0.010 |
Why?
|